SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps

Published:2022-02-25 Issue:2 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Sigler Rachel¹^ORCID,Aslam Saima¹^ORCID

Affiliation:

1. Division of Infectious Diseases and Global Public Health University of California San Diego La Jolla California USA

Funder

Cystic Fibrosis Foundation

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13809

Reference31 articles.

1. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

2. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study

3. Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

4. Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants

5. Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post‐acute sequelae of COVID‐19 in solid organ transplant recipients;Transplant Infectious Disease;2023-11-03

2. Torque teno virus viral load predicts SARS‐CoV‐2 vaccine response in kidney transplant recipients;Journal of Medical Virology;2023-07

3. Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors;Current Opinion in Organ Transplantation;2023-02-15

4. Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies;Transplant International;2022-10-04

5. SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients;Vaccines;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3